|
C1ORF26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18760010106678E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.88149562175522E-11 |
| Normal-vs-Stage2 |
3.967900E-04 |
| Normal-vs-Stage3 |
3.601100E-04 |
| Normal-vs-Stage4 |
5.696700E-03 |
| Stage1-vs-Stage2 |
9.633200E-01 |
| Stage1-vs-Stage3 |
4.622000E-01 |
| Stage1-vs-Stage4 |
7.262400E-01 |
| Stage2-vs-Stage3 |
6.088200E-01 |
| Stage2-vs-Stage4 |
7.344800E-01 |
| Stage3-vs-Stage4 |
4.439400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.65929969553736E-10 |
| Normal-vs-AfricanAmerican |
1.64769999866365E-08 |
| Normal-vs-Asian |
4.376000E-03 |
| Caucasian-vs-AfricanAmerican |
6.157800E-01 |
| Caucasian-vs-Asian |
9.271400E-01 |
| AfricanAmerican-vs-Asian |
7.687000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00409680570124E-11 |
| Normal-vs-Female |
5.201600E-04 |
| Male-vs-Female |
3.436200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.00760000004896E-06 |
| Normal-vs-Extreme_Weight |
4.65660843218529E-12 |
| Normal-vs-Obese |
2.03170000001585E-06 |
| Normal-vs-Extreme_Obese |
4.578300E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.931400E-01 |
| Normal_Weight-vs-Obese |
6.504600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.217600E-01 |
| Extreme_Weight-vs-Obese |
8.519500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.119200E-01 |
| Obese-vs-Extreme_Obese |
6.173400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.356990E-03 |
| Normal-vs-Age(41-60Yrs) |
2.33309999986275E-07 |
| Normal-vs-Age(61-80Yrs) |
6.5426997153395E-11 |
| Normal-vs-Age(81-100Yrs) |
2.05780004147726E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.761400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.029700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.038400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.987600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.597570E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.326610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.72309968913009E-11 |
| Normal-VS-Type2 PRCC |
9.54819999954282E-07 |
| Normal-VS-KIRP CIMP |
4.772500E-04 |
| Normal-VS-Unclassified PRCC |
5.215900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.343600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.162200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.294000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.715800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.985600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.130600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.32160007568916E-10 |
| Normal-vs-N1 |
6.045500E-02 |
| Normal-vs-N2 |
1.818810E-01 |
| N0-vs-N1 |
5.331600E-02 |
| N0-vs-N2 |
9.090000E-01 |
| N1-vs-N2 |
4.505800E-01 |
|
|
